SAGIMET BIOSCIENCES Series A (SGMT) insider trading activity (SEC Form 4). Over the trailing 90 days, SGMT insiders filed 0 purchases totalling $0 and 5 sales totalling $4.5M — net SELLING of $4.5M. Most recent filing: Aug 17, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Kemble George | Dir | S SaleOE | — | $10.23 | $3.6M | filing |
| Aug 12, 2026 | Kemble George | Dir | S SaleOE | — | $9.95 | $201K | filing |
| Jul 22, 2026 | Kemble George | Dir | S Sale | — | $7.46 | $141K | filing |
| Jul 22, 2026 | Rozek Elizabeth | Chief Legal, Admin. Officer | S Sale | — | $7.76 | $82K | filing |
| Jul 22, 2026 | Happel David | Pres, CEO | S Sale | — | $7.76 | $497K | filing |